FDAnews Drug Daily Bulletin

PURE BIOSCIENCE REPORTS SECOND QUARTER AND SIX-MONTH RESULTS

March 20, 2006
A A

Pure Bioscience today reported financial results for the second quarter and six-month period ended January 31, 2006. For the second quarter the Company reported revenues of $59,442 from continuing operations, as compared with revenues of $50,964 in the second quarter of the prior year. The Company reported a second quarter loss from continuing operations before taxes of ($919,156), or ($0.05) per share, as compared with a loss of ($771,829), or ($0.04) per share in the same period last year.

Yahoo News (http://biz.yahoo.com/prnews/060317/laf016.html?.v=47)